Stock DERMA SCIENCES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Derma Sciences Inc

Equities

US2498275021

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Derma Sciences Inc

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Derma Sciences, Inc. And Encourages Investors To Contact The Firm For Additional Information
BU
DERMA SCIENCES, INC. Former SEC Attorney Willie Briscoe Believes the Acquisition by Integra LifeSciences Holdings Corporation May be Unfair to Shareholders
BU
Derma Sciences : Buys MEDIHONEY® Brand From Long-Term Partner
BU
Derma Sciences : to Be Acquired by Integra LifeSciences for $7.00 Per Share of Common Stock in Cash
BU
Derma Sciences : to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
BU
Derma Sciences : Reports 2016 Third Quarter Financial Results
BU
Derma Sciences : to Hold Third Quarter Financial Results Conference Call on November 10th
BU
Derma Sciences : to Present at the Ladenburg Thalmann 2016 Healthcare Conference
BU
Derma Sciences : Completes the Sale of Its First Aid Products Division
BU
Derma Sciences : Receives Reimbursement Coding for New MEDIHONEY® Hydrogel Dressings
BU
Derma Sciences : rsquo; AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor NGS
BU
Derma Sciences : Names Russell Olsen President of Advanced Wound Care
BU
Derma Sciences : Reports 2016 Second Quarter Financial Results
BU
Derma Sciences : to Hold Second Quarter Financial Results Conference Call on August 9th
BU
Derma Sciences : to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products
BU
Derma Sciences : to Sell First Aid Products Division for Approximately $12.2 Million
BU
Derma Sciences : Reports 2016 First Quarter Financial Results
BU
Derma Sciences : to Hold First Quarter Financial Results Conference Call on May 11th
BU
Derma Sciences : Announces AMNIOEXCEL® Is Now Eligible for Reimbursement by Medicare Administrative Contractor CGS
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Derma Sciences Inc